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Abstract
G4-DNA is a four-stranded structure that is formed by guanine-rich sequences. We report here the
purification and characterization of a novel G4-DNA binding protein from Tetrahymena thermophila,
designated TGP2. TGP2 was found to preferentially bind to G4-DNA oligonucleotides with adjacent single-
stranded domains containing phosphorylated 5‘ ends and the sequence element, 5‘-ACTG-3‘. The amino acid
sequence of TGP2 has high similarity to dihydrolipoamide dehydrogenase (DLDH) from a variety of species,
and TGP2 was shown to have DLDH activity. Purified DLDH from porcine heart and bovine intestinal
mucosa were shown to bind specifically to G4-DNA oligonucleotides. On the basis of these results we
conclude that TGP2 is DLDH in T. thermophila and suggest that the G4-DNA binding capability of TGP2/
DLDH may be biologically relevant.
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ABSTRACT: G4-DNA is a four-stranded structure that is formed by guanine-rich sequences. We report
here the purification and characterization of a novel G4-DNA binding protein from Tetrahymena
thermophila, designated TGP2. TGP2 was found to preferentially bind to G4-DNA oligonucleotides
with adjacent single-stranded domains containing phosphorylated 5′ ends and the sequence element, 5′-
ACTG-3′. The amino acid sequence of TGP2 has high similarity to dihydrolipoamide dehydrogenase
(DLDH) from a variety of species, and TGP2 was shown to have DLDH activity. Purified DLDH from
porcine heart and bovine intestinal mucosa were shown to bind specifically to G4-DNA oligonucleotides.
On the basis of these results we conclude that TGP2 is DLDH in T. thermophila and suggest that the
G4-DNA binding capability of TGP2/DLDH may be biologically relevant.
DNA can adopt a variety of structures in addition to the
classical double helix. G4-DNA is one of these structures.
It is a four-stranded DNA structure containing a G-quartet
structural motif and is characterized by high stability and
selective cation binding (1). Many G-rich sequences are
capable of forming G4-DNA structures in vitro. These
include telomeric sequences (2, 3), the immunoglobulin
switch region (4), a retrovirus dimerization domain (5),
recombination hot spots (6), and gene regulatory regions (7,
8). Nevertheless, direct evidence for a biological role for
G4 structures has yet to be reported.
One approach to assessing the biological relevance of G4-
DNA is to search for proteins that bind specifically to this
structure. Several such G4-DNA binding proteins have been
reported, including MyoD, a transcription factor that induces
myogenesis (9), QUAD, a protein from hepatocyte chromatin
of rabbits (10), topoisomerase II (11), and TGP1 (12), which
was found to bind to G4-DNA with single-stranded domains.
Other proteins have been shown to bind and interact
dynamically with G4-DNA substrates. The â-subunit of the
telosome in the ciliate Oxytricha and RAP1 in yeast were
both found to promote formation of the G4 structure in
telomeric DNA (13, 14). The KEM1 gene product in yeast
was identified as a G4-DNA-dependent nuclease, and a
homozygous deletion of the KEM1 gene blocks meiotic cells
at the 4N stage (15, 16). Taken together, these findings
suggest that G4-DNA has important biological functions in
vivo.
Dihydrolipoamide dehydrogenase (DLDH)1 is a ubiquitous
and highly conserved enzyme that participates in the oxida-
tion of dihydrolipoamide and the reduction of NAD+ (for
review, see ref 17).
This enzyme is an integral part of the pyruvate dehydro-
genase multienzyme complex catalyzing the formation of
acetyl-CoA from pyruvate. In addition to this role, this
disulfide oxidoreductase also catalyzes the conversion of
glycine to N5,N10-methylenetetrahydrofolate, CO2, and NH4+
(18). Several new findings suggest additional functions of
this enzyme. In archaebacteria, where 2-oxoacids are
metabolized by different enzymes, DLDH is still present,
but as a noncomplexed enzyme (19). Moreover, in the
parasitic protozoan, Trypanosoma brucei, DLDH has been
found in the mammalian bloodstream form of the parasite,
despite the absence of the multienzyme complexes with
which this enzyme is usually associated (20). The Trypa-
nosoma enzyme is found to be loosely associated with the
inner surface of the plasma membrane, which is an unusual
location compared with the more common location in
mitochondria (21).
We report here the purification and characterization of a
second Tetrahymena thermophila G4-DNA binding protein,
designated TGP2. The amino acid sequence from the amino
terminal of TGP2 has high similarity with DLDH from a
variety of species, including humans. We show that TGP2
has DLDH activity and that two purified commercial
preparations of DLDH from other sources have NAD+-
dependent G4-DNA binding activity. These data strongly
suggest that TGP2 is DLDH in Tetrahymena and that this
enzyme has G4-DNA binding activity. Possible roles for
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TGP2 in the context of these observations are discussed.
EXPERIMENTAL PROCEDURES
DNA Oligonucleotides. All oligonucleotides (Tet4, Oxy4,
T, M, Y, Y-G, R, G, P, Z, XYa, XYb, and XYc) were
synthesized by phosphoramidite chemistry (Nucleic Acid
Research Facility at Iowa Sate University and Midland
Certified Reagent Co.) and purified as previously described
(2).
Chromatography Media. Chromatofocusing was carried
out using matrix PBE94 and Polybuffer96 (Pharmacia
Biotech). Protein samples were concentrated using Centricon
10 spin concentrator devices (Amicon).
DLDH Enzymes and Substrates. Dihydrolipoamide de-
hydrogenase (DLDH) assays were conducted using NAD+,
DL-lipoamide (DL-thioctic acid amide), and DLDH from
porcine heart, torula yeast, and bovine intestinal mucosa
(Sigma). Escherichia coli DLDH was the generous gift of
Dr. C. H. Williams.
Tetrahymena Cell Culture and Extract Preparation. Cells
were cultured and extracted as previously described (12).
Briefly, T. thermophila strain C3V was grown to midlog
phase and harvested without mating. The whole cell lysate
was obtained as previously described (12), and the 100000g
supernatant (S100) was aliquoted and immediately frozen
in liquid nitrogen. The protease inhibitors leupeptin (0.01
mM), pepstatin (0.01 mM), and Pefabloc (0.1 mM) (Boeh-
ringer Mannheim) were added to all S100 aliquots before
they were frozen.
DNA Oligonucleotide Purification and 5′ End Radiola-
beling. DNA oligonucleotides were gel purified and desalted
as previously described (12). Briefly, DNA nucleotides were
gel purified by 20% polyacrylamide gels containing 7 M urea
and 1 TBE buffer. The desired oligonucleotides were
visualized by UV shadowing, excised, and desalted by C18
chromatography (2). Oligonucleotides were radiolabeled at
the 5′ end with T4 polynucleotide kinase (New England
Biolabs) according to standard procedures (22).
Electrophoretic Mobility Retardation and Competition
Assay. An amount of 312.5 pmol of 5′ 32P-labeled probe
was boiled for 5 min in the presence of 67 mM KCl, 17
mM MgCl2, and 17 mM Tris-HCl (pH 7.5) and allowed to
cool to room temperature for at least 30 min to permit
formation of G4 structures. Fifty micrograms of poly(dI-
dC)/poly(dI-dC) (nonspecific competitor) and 20% (v/v)
glycerol were added after cooling. The mixture was then
diluted 10-fold in doubly distilled water, making the 32P-
probe final concentration 0.125 íM. Based on the result of
mobility retardation assays, over 97% of 32P-Y formed a G4
structure (Y4) under these conditions (Figure 1). Five
microliters of 0.125 íM 32P-probe was mixed with the protein
solution to produce a final volume of 20 íL. Final
concentrations in the reaction mixture were 31.25 nM 32P-
Y, 0.8 mM KCl, 0.2 mM MgCl2, and 0.2 mM Tris-HCl.
Unless otherwise noted, all oligonucleotides used in competi-
tion assays were 5′ phosphorylated using ATP and T4
polynucleotide kinase (New England Biolabs). Labeled or
unlabeled oligonucleotides were individually heated and
cooled under conditions identical to those of the probe to
allow individual G4 formation. Once the probe and com-
petitor were combined, protein solution was added to produce
a final volume of 20 íL. The reaction mixtures were
incubated on ice for 20 min and loaded onto a 6%
nondenaturing polyacrylamide gel in 0.6 TBE. Electro-
phoresis at 10 V/cm was carried out for 90 min at room
temperature. The gels were then dried and exposed to Kodak
XAR-5 film or phosphor screens. Radioactivity in individual
bands was quantitated using a Molecular Dynamics Phos-
phorImager. The ability of a variety of oligonucleotides to
compete with 32P-Y4 for TGP2 binding (Figure 5D) was
evaluated by comparison of the average slopes of a line
connecting each molar excess point of pY. For example,
pZ decreased the 32P-Y4 binding activity to 100%, 89%,
78%, 65%, and 62%, when pZ was added at the molar excess
FIGURE 1: TGP2 specifically binds to the G4-DNA molecule Y4.
Crude cell extract from T. thermophila (S100) and purified TGP2
(S10065 and F32) were complexed to 32P-labeled Y or Y4 and
analyzed by a gel mobility retardation assay. Lane 1: Negative
control (N) lacking any protein but containing the reaction mixture
and 32P-Y. The monomeric (Y) and tetrameric forms (Y4) of the
substrate have significantly different mobilities in the gel (arrows).
Lane 2: S100 shifted 32P-Y4 to several lower mobility positions
corresponding to G4-DNA binding proteins TGP1 and TGP2. Lane
3: Heat-purified TGP2 (S10065) illustrating that TGP2 is heat stable.
Lane 4: TGP2 from chromatofocusing column Fraction 32 (F32)
plus the 32P-Y reaction mixture showed a single-shifted band. Lanes
5, 6 and 7: S100, S10065, and F32, respectively, were incubated
with the 32P-Y-G reaction mixture. Oligo Y-G lacks the guanine-
rich region necessary for Y4 formation, so no Y4 is formed. No
shifted bands were observed. Substrate degradation seen in Lanes
5 resulted from nucleases in this relatively impure protein prepara-
tion. Lane 8, 9, and 10: The effects of altering reaction conditions
on TGP2-Y4 complex formation. As would be expected for a G4-
DNA molecule, potassium ions profoundly enhance Y4 formation.
In the absence of potassium, very little Y4 forms, and consequently
only a small amount of TGP2-Y4 complex is observed. Lane 11:
85 units of mung bean nuclease was incubated with the reaction
mixture after formation of the TGP2-Y4 complex. Over 90% of
32P-Y was digested, presumably in the single-stranded domain,
suggesting that the single-stranded portion is not well protected by
TGP2 in the complex.
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of 0-fold, 2-fold, 4-fold, 12.5-fold, and 50-fold, respectively
(Figure 5B). Since a more negative slope correlates with
more efficient competition, the percent of decrease of the
binding activity was converted to the slope between two
molar excess points. Hence, pZ had slopes of -5.50, -5.48,
-2.77, and -0.75. The average slope of the first three slopes
for -4.58, pZ, was then compared to the average slope of
pY, 23.87, and represented as percent competition (Figure
5D; all the fourth slopes were not included for the averages
because some of the fourth slopes showed saturation). The
percent competition of pZ was found to be about 19% of
that of pY.
Purification of TGP2. S100 (20 mL) was thawed and
immediately incubated in a 65 °C water bath for 20 min.
Heat-treated S100, which contained a large amount of
denatured protein, was centrifuged at 14 000 rpm for 15 min.
Supernatant (S10065) was collected, and white pellets were
discarded. A chromatofocusing column packed with PBE94
matrix was equilibrated with 25 mM ethanolamine-HCl, pH
9.05, at the rate of 1 mL/min until the pH of effluent reached
9.00. Polybuffer96 was diluted 10-fold with ddH2O and
adjusted to pH 6.5 as the eluting buffer. Five milliliters of
eluting buffer was loaded onto the column at 0.4 mL/min
followed by 18 mL of S10065. TGP2 was then eluted at
a flow rate of 0.4 mL/min and collected in 7 mL fractions.
The average difference of pH between each fraction was
approximately 0.07 unit.
SDS-PAGE Analysis. Chromatofocusing fractions were
tested for TGP2 activity in mobility retardation assays.
Fractions with TGP2 activity were concentrated 29-fold
using Centricon 10 spin concentrators. Samples were
electrophoresed through a 10% polyacrylamide gel using the
standard Laemmli method (23). The sample buffer contained
25% 4 Tris-HCl/SDS, pH 6.8 (v/v, 0.5 M Tris-HCl
containing 0.4% SDS), 4% SDS (w/v), 2% 2-mercaptoeth-
anol (v/v) or 3% DTT (w/v), and 0.001% bromophenol blue
FIGURE 2: (A) TGP2 can be separated from other TGPs by chromatofocusing. Fractions with descending pH [shown in (B)] were tested
for Y4 binding activity. Several Y4 binding proteins, including TGP1 (12) and an as yet uncharacterized protein, TGP3, appeared in earlier
fractions (F7 to F11). TGP2 was concentrated in fractions 21-43. Fractions containing higher concentrations of TGP2 showed an additional
band which was determined to be a supershift caused by TGP2. Fraction 32 (F32) was found in further analysis to contain the highest Y4
binding activity. (B) TGP2 has dihydrolipoamide dehydrogenase (DLDH) activity. After determination of a portion of the amino acid
sequence for TGP2 and alignment with known sequences, very high similarity was observed between TGP2 and DLDH from a variety of
species. DLDH assays confirmed that the chromatofocusing fraction containing TGP2 with the highest Y4 binding activity also had the
highest DLDH activity. Thus, TGP2 is likely to be identical to DLDH in Tetrahymena.
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(w/v). All samples were mixed with sample buffer in a 1 to
1 ratio, followed by either heating to 95 °C or room-
temperature incubation for 5 min, before loading onto the
gel. The gel was run at 15 mA through a stacking gel (4%
polyacrylamide), and at 20 mA in the separating gel (10%
polyacrylamide). Electrophoresis was stopped when the
bromophenol blue reached the bottom edge of the gel. The
gel was then silver stained according to standard procedures.
Protein Sequencing. The concentrated chromatofocusing
fraction showing the TGP2 band with the fewest degradation
products (F29, Figure 3) was used for amino terminal
sequencing. The concentrated fraction was separated by 10%
SDS-PAGE, followed by 1 h electrotransferring to Transblot
PVDF membrane (Bio-Rad). The membrane was then
stained with 0.1% Coomassie Brilliant Blue (w/v) in 10%
methanol (15 min), and destained in 45% methanol, 7%
acetic acid (15 min) followed by a second destaining in 90%
methanol, 7% acetic acid (2 min). The 53 kDa band was
sliced out after air-drying overnight and subjected to Edman
degradation sequence determination at the Protein Facility
at Iowa State University. Protein concentration was mea-
sured by the method of Bradford using bovine serum albumin
(BSA) as a standard (23).
Dihydrolipoamide Synthesis and DLDH Assay. Dihydro-
lipoamide was synthesized, and the DLDH activity assay was
performed as described by Patel et al., with minor modifica-
tion (24). DL-dihydrolipoamide was synthesized as described,
except that the dried dihydrolipoamide was not further
purified by HPLC. The final concentrations of components
in the DLDH assay were 100 mM potassium phosphate, pH
8.0, 1.5 mM EDTA, 3.0 mM DL-dihydrolipoamide in 95%
ethanol, and 3.0 mM NAD+. After the addition of 50 íL of
enzyme solution in a total reaction volume of 1 mL, the
increase in NADH concentration was monitored at 340 nm
using a DU-7400 spectrophotometer (Beckman). Only the
absorbances obtained during the first three minutes were used
for measurement of the DLDH reaction rate, since the
increase of absorbances in this period was found to be linear
(NADH is an inhibitor of DLDH).
FIGURE 3: (A): TGP2 has a molecular mass of approximately 53 kDa and dimerizes in SDS in the absence of boiling. SDS-PAGE (10%
polyacrylamide gel) analysis of concentrated chromatofocusing column fractions showed a major species with an apparent molecular mass
of 53 kDa which was assigned to TGP2. The intensity of TGP2 increased from F29 to F33 and decreased thereafter. An equal amount of
fractions was loaded in both plus and minus boiling treatment lanes. Degradation products were pronounced in fractions that were boiled
in SDS prior to loading on the gel. In the absence of boiling, a band appeared at 110 kDa, and the TGP2 and degradation product bands
decreased in intensity significantly. The 110 kDa band was tentatively identified as the previously described dimer form of TGP2. (B) The
sequence of the first 33 amino acids of TGP2 was determined by Edman degradation sequencing. The underscore ( ) indicates ambiguous
amino acids. Alignment with protein sequences in the SWISSPRO database revealed high similarity with DLDH from a variety of species.
The “Score” column indicates the degree of similarity, with the perfect score being 182. The “Predicted No.” column is the number of
results expected by chance to have a score greater than or equal to the score of the result obtained.
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Calculation of Apparent Kd. Bound and unbound oligo-
nucleotides were quantified using a Molecular Dynamics
PhosphorImager. A constant amount of 32P-Y mixture (4.7
nmol 32P-Y4) was added to increasing amounts of TGP2
(chromatofocusing fraction 32). An apparent Kd was esti-
mated from the resultant hyperbolic binding isotherm as
described previously (Figure 6B) (23).
RESULTS
TGP2 Specifically Binds to a Parallel G4-DNA Structure.
An oligonucleotide designated Y (1) was used for this study.
This oligonucleotide has been well studied and shown to
form a stable parallel-stranded G4 structure, Y4 (1, 12). At
low concentrations of 32P-Y (31.25 nM) and low concentra-
tion of potassium ion (0.8 mM), over 97% of 32P-Y forms
the G4 structure 32P-Y4 (Figure 1, lane 1). Crude cell
extracts from T. thermophila (S100) were found to contain
more than one 32P-Y4 binding protein, all designated with
the prefix TGP (Tetrahymena thermophila G4-binding
Protein). These proteins included TGP1, which has already
been reported (12), TGP2, described herein, and an as yet
uncharacterized protein, TGP3 (Figure 2A). All TGPs bound
to 32P-Y4, but not the monomer, 32P-Y. This is clearly shown
by the mobility shift assay depicted in Figure 2A, F29 to
F39, in which all 32P-Y4 (tetramer) was shifted to the top of
the gel but the monomeric 32P-Y species remained at the
FIGURE 4: Commercial preparations of DLDH from two other species also showed Y4 binding activity in the presence of NAD+. (A)
Mobility retardation assay using several DLDH preparations from different species. TGP2 (F32, 0.013 mg/mL), type III porcine heart
DLDH (PH, 0.034 mg/mL), bovine intestinal mucosa DLDH (BIM, 0.022 mg/mL), torula yeast DLDH (TY, 0.025 mg/mL), and E. coli
DLDH (EC, 0.028 mg/mL) were incubated with 32P-Y and analyzed on a 6% nondenaturing polyacrylamide gel. NAD+ was added to the
indicated final concentrations. NAD+ concentration affected the degree of binding in all cases, with TGP2 being most sensitive to NAD+
inhibition of Y4 binding. (B) Quantitation of the autoradiogram shown in panel A. All readings were subtracted from a background reading
taken from the region corresponding to the TGP-4 complex mobility in the lane labeled “cont.”, which did not contain any protein.
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bottom of the gel. The binding specificity was further
confirmed by the fact that the molecule 32P-Y-G, which lacks
a G-rich domain and therefore cannot form G4-DNA, was
not shifted by TGP1 or TGP2 (Figure 1, lanes 5, 6, and 7).
As with most G4-DNA structures, potassium ions were found
to be important for stabilizing the tetramer structure while
magnesium ions were not. In the absence of potassium, over
93% of 32P-Y remained monomeric and very little TGP2
binding activity was observed (compare TGP2, 32P-Y4, and
32P-Y radioactivity on lanes 4 and 8 in Figure 1). This
further strengthened the proposal that without the formation
of tetramer 32P-Y4, TGP2 could not bind to the 32P-Y
monomer. Digestion of 32P-Y4 after formation of the
TGP2-32P-Y4 complex with mung bean nuclease (Figure
FIGURE 5: TGP2 specifically binds to parallel-stranded G4-DNA and shows sequence specificity at the 5′ end. Panels A, B, and C show
the results of competition experiments analyzed by mobility shift assays. All oligonucleotides used are shown in panel E. (A) Two telomeric
oligonucleotides (pTet4, pOxy4) with G-rich sequences and three oligonucleotides (pXYa, pXYb, pXYc) with different lengths were used
to test telomeric binding ability of TGP2 and the substrate length requirement. (B) Competition with Y oligonucleotide with and without
a 5′ phosphate showed that TGP2 bound specifically to 5′ phosphorylated species. Evaluation of the competitive ability of pZ, pM, and pP
showed that TGP2 binding was sensitive to changes in the 5′ proximal 6 nucleotides. (C) competition with pT showed that 21 nucleotides
were sufficient for TGP2 binding. Competition with pG, pR, and pK showed that changing 5′ nucleotides 1-4 reduces TGP2 binding to
different levels. Combining these results revealed a preferred 5′ binding sequence, 5′-ACTG-3′. (D) Summary of the competitive abilities
of the oligonucleotides used in this set of experiments. (E) The sequences of all the oligonucleotides used and their changes compared to
pY. Nucleotide changes or deletions are underlined. pXYa, pXYb, and pXYc are truncated forms of pY.
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1, lane 11) and with proteinase K (data not shown) both
resulted in the disappearance of the shifted bands, confirming
that the shifted band was a complex of protein and DNA.
Purification and Amino-Terminal Sequencing of TGP2.
After S100 was heat treated as described in Experimental
Procedures, 32P-Y4 binding activity remained in the super-
natant, a characteristic of the heat stable DLDH enzyme
(Figure 1, lane 3). In the heat purification, at least 90% of
the total cellular protein was precipitated at 65 °C, as
calculated by comparing protein concentrations in S100 and
S10065 (supernatant of heat-denatured S100).
TGP2 was further purified by chromatofocusing, a method
that fractionates protein components according to their pI,
with resolution of 0.07 pH unit. TGP2 was found to elute
between pH 7.30 and 6.50 (Figure 2A,B). The fraction that
showed highest TGP2 activity was fraction 32 (F32, data
not shown) with a pH value of 6.75. SDS-PAGE analysis
of F29 to F37 showed that the intensity of a predominant
band at 53 kDa increased from F29 to F33 and decreased
by F37 (Figure 3A). The intensities of one predominant
slightly lower band (47 kDa) and several minor lower
bands increased and decreased in the same pattern as the 53
kDa band. Concentrated fractions that were not boiled prior
to analysis showed a clear band at 110 kDa with the same
intensity changes as the 53 kDa band. Furthermore, samples
without boiling treatment all showed a decrease in intensities
of bands equal to or lower than 53 kDa. Taken together,
these data suggest that the 53 kDa band was TGP2 and that
the lower bands (<53 kDa) were degradation products
resulting from the heat treatment or preexisting in a multi-
meric form prior to heat denaturation in SDS. The appear-
ance of the 110 kDa band was consistent with the dimer-
ization of TGP2, a previously reported characteristic of
DLDH (25). UV cross-linking experiments carried out using
standard protein-Y4 reaction mixtures showed that both the
53 and 47 kDa bands bound to 32P-Y4 (data not shown),
supporting the notion that they were different forms of the
same protein.
FIGURE 6: Determination of the apparent equilibrium dissociation constant for the complex of TGP2 and 32P-Y. (A) Mobility shift assay
in which 32P-Y (4.7 nM) was incubated with the indicated concentrations of TGP2 (0.49 to 2080 nM). (B) An apparent Kd was estimated
from the resultant hyperbolic binding isotherm (50% of the maximal binding).
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Edman degradation sequencing of the 53 kDa protein
revealed the sequence of 33 amino acids from the amino
terminus (Figure 3B). After searching in the SWISSPRO
database using the BLITZ server and MPsrch program (26),
it was found that dihyrolipoamide dehydrogenases (DLDH)
from a variety of species had high similarity to TGP2 (Figure
3B). The heat stability of DLDH (27) and its ability to form
homodimer functional units (17) correlated well with the
observed characteristics of TGP2, strongly suggesting that
TGP2 was DLDH in T. thermophila.
DLDH ActiVity of TGP2. To test further the idea that
DLDH and TGP2 were the same protein, a DLDH activity
assay was performed on the chromatofocusing fractions. This
assay showed that a DLDH activity gradient existed which
increased from F21 to F32 and decreased from F32 to F43
(Figure 2B). The highest DLDH activity appeared in F32.
Negative controls lacking either dihydrolipoamide or NAD+
showed no increased enzyme activity after the addition of
F32, confirming the substrate specificity of F32. The
fractions that expressed DLDH activity were strongly cor-
related with the fractions showing 32P-Y4 binding activity.
The fraction which showed the highest 32P-Y4 binding
activity among the fractions, was also the fraction expressing
highest DLDH activity. This further supported the proposal
that TGP2 is DLDH in T. thermophila. On the basis of
measured specific activities of DLDH/TGP2 in purification
stages S100, S10065, and F32, we attained a minimum
purification of 30-fold for DLDH by the protocol described
here (Table 1). The fractions collected from the cation
exchange column also showed the same pattern of activities
and correlation between Y4 binding and DLDH activity. The
53kD band also appeared at the highest concentration in the
fraction with the highest amount of DLDH activity and Y4
binding activity (data not shown).
DLDH of Other Species Show NAD+-Dependent Binding
to 32P-Y4. To determine whether DLDHs of other species
have 32P-Y4 binding activity, several purified DLDHs from
different species were tested in gel mobility retardation
assays. DLDHs from porcine heart, bovine intestinal mu-
cosa, torula yeast, and E. coli showed no 32P-Y4 binding
activity without addition of NAD+ to the reaction mixtures.
However, when 0.3 nM NAD+ was added to the reaction
mixtures, porcine heart and bovine intestinal mucosa DLDH
showed significant 32P-Y4 binding activity, but torula yeast
and E. coli DLDHs still showed no significant activity
(Figure 4A,B). When the NAD+ concentration was increased
from 6 to 12 mM, 32P-Y4 binding activities of TGP2, porcine
heart, and Bovine Intestinal Mucosa DLDH all decreased.
The extent of decrease in the activities varied from species
to species, with the greatest extent in TGP2, followed by
porcine heart DLDH, and with the least decrease seen with
bovine intestinal mucosa DLDH. These results showed that
DLDHs of certain species could bind to 32P-Y4 and that this
binding was dependent upon NAD+ concentration.
Sequence and Structural Requirements for TGP2 Binding.
TGP2 requires a substrate with both a G4-DNA and single-
stranded domain for optimal binding. We designed a series
of oligonucleotides to further explore this characteristic.
pXYa, pXYb, and pXYc are truncated forms of pY (the
lowercase p indicates the presence of a nonradioactive 5′
phosphate) with nucleotides removed from the 5′ end, and
pT contains an internal sequence change and deletion (Figure
5E). These oligonucleotides were used as competitors to
investigate the length specificity of TGP2 binding with regard
to the single-strand domain. All three truncated oligonucle-
otides were found to have low competitive abilities (Figure
5A,D). However, pT, which was 21 nucleotides long but
retained the 5′ end sequence of pY, was as efficient a
competitor as was pY. Therefore, we concluded that length
was a less critical factor than was the sequence at the 5′ end
of the single-stranded domain.
In another set of experiments it was observed that the
nonphosphorylated form of Y was a poor competitor for
TGP2 binding relative to 32P-Y. However, when the
nonradiolabeled Y competitor was 5′ phosphorylated (pY),
its ability to compete with 32P-Y4 for binding to TGP2
increased dramatically (Figure 5B). Thus, TGP2 requires
the 5′ phosphate for optimal binding activity and may
recognize this phosphate group directly.
On the basis of the experiments described above, TGP2
requires a substrate with a G4 domain adjacent to a single-
stranded domain for binding. Furthermore, the single
stranded domain has strong sequence constraints at the 5′
end and must be 5′ phosphorylated. The sequence specificity
of TGP2 was further tested using a series of oligonucleotides
related to the pY4 substrate. pZ contained a 16 nucleotide
random sequence at the 5′ end of the single-stranded domain,
but it retained the G-rich domain and the ability to form G4-
DNA (Figure 5E). pZ showed very low competitive ability
with pY (Figure 5B,D). Further investigation of sequence
specificity by using pM (altered middle portion of the single-
stranded sequence), pP (altered the last 5 nucleotides from
the 5′ end) as competitors, clearly showed that changing the
last five nucleotides of the original pY sequence decreased
the ability of the altered molecules to compete with 32P-Y4
for TGP2 binding. These data support the proposal that
TGP2 specifically binds to oligonucleotides that have a
defined sequence in the 5′ single-stranded domain, but
indicate that the sequence requirements starting from nucle-
otide 6 to 16 were less specific.
To narrow further the sequence requirements for TGP2
binding, another series of oligonucleotides, pT, pR, pG, and
pK, was used as competitors (Figure 5E). The ability of pT
to compete effectively indicated that nucleotide number 5
from the 5′ was not highly sequence constrained. In contrast,
the inability of oligonucleotides pR and pG to compete
effectively showed that nucleotides 1-4 were critical (Figure
5C). Oligonucleotide pK, which has a single nucleotide
change at position 3 from the 5′ end, showed a minor but
significant decrease in competitive ability, indicating that
nucleotide 3 was also sequence specific. Oligonucleotide
Table 1: Specific Activities of Dihydrolipoamide Dehydrogenases
from Different Species
species/source preparation
specific activity
(units/mg)
T. thermophila crude extract (S100) 0.44
T. thermophila heat purified (S10065) 1.68
T. thermophila chromatofocusing (F32) 13.78
Haloferax Volcanii crude extract 0.1(37)
Haloferax Volcanii purified enzyme 16.1(37)
porcine heart purified enzyme 100-200(38)
torula yeast purified enzyme 40-100(38)
bovine intestinal mucosa purified enzyme 100-200(38)
E. coli purified enzyme 120(39)
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pG which had two nucleotide changes at positions 3 and 4
showed much less competitive ability compared to pK, which
had a change at position 3, indicating that nucleotide 4 was
also important for binding specificity.
Considering the results of all the competition assays and
the results using 32P-Y-G as probe (Figure 1), we conclude
that TGP2 binds to a substrate with a G4-DNA domain at
the 3′ end, a single-stranded domain at the 5′ end, requires
a 5′ phosphate, and requires the 5′ sequence 5′-ACTG-3′
for optimal binding.
Dimerization and Apparent Kd of TGP2 Using 32P-Y4.
When relatively high concentrations of TGP2 were added
to a typical 32P-Y4 reaction mixture, a band of lower mobility
appeared above the characteristic TGP2-Y4 complex band
(Figure 6, 0.49-2.08 íM). This band was designated the
TGP2 supershift band. Since the intensities of the charac-
teristic TGP2 band decreased when the supershift appeared
(Figure 2A, F25-F35; Figure 6A, 0.49-2.08 íM), it was
proposed that TGP2 was shifted to the higher position.
Referring to the resultant hyperbolic binding isotherm (Figure
6B), the supershift band appeared after the binding activity
had reached its maximum (95%). Therefore, it was reason-
able to postulate that since the supershift appeared when all
available 32P-Y4 had been bound, it represents the binding
of additional TGP2 to Y4-TGP2 complexes. Since DLDH
forms dimers, it is likely that this supershift represents the
dimerization event. The Kd of TGP2 with 32P-Y4 was
estimated from the isotherm curve (Figure 6B) to be
approximately 1.5  10-7 M.
DISCUSSION
Our studies showed that a G4-DNA binding protein,
TGP2, copurified with DLDH enzyme activity (Figure
2A,B). Moreover, purified DLDH from porcine heart and
bovine intestinal mucosa bound to the G4-DNA substrate
32P-Y4 and shifted it to the same position as did TGP2 in
mobility retardation assays (Figure 4A), indicating a shared
G4-DNA binding activity for DLDH from different species.
The high similarity between amino acid sequences of TGP2
and a variety of DLDHs (Figure 3B) provided additional
evidence that TGP2 was DLDH in T. thermophila. Hence,
we propose that TGP2 has dual functions as a G4-DNA
binding protein and the metabolic enzyme DLDH.
Purification and characterization of DLDH from T. ther-
mophila has not been previously reported. DLDH from
several species, including humans, has been purified and is
apparently encoded by a single gene (28, 29). If TGP2 is
DLDH in T. thermophila and if the DLDH is coded by a
single gene, TGP2 and DLDH will have the same gene
sequence. Cloning the TGP2 gene and testing the expressed
gene product for DLDH activity and G4-DNA binding will
definitively demonstrate that TGP2 is DLDH in T. thermo-
phila.
The effect of NAD+ on the binding of TGP2 and other
DLDHs to 32P-Y4 is significant and interesting. NAD+ is
the oxidizing substrate in the forward reaction of DLDH (17).
In our studies, 0.3 mM NAD+ increased the binding of
TGP2, porcine heart DLDH, and bovine intestinal mucosa
DLDH to 32P-Y4. However, 6 and 12 mM NAD+ signifi-
cantly decreased the binding of TGP2 and PH-DLDH to 32P-
Y4 (Figure 4A,B). Since pY4 was not an inhibitor of the
DLDH forward reaction (data not shown), it is likely that
the G4-DNA binding site is different from the enzymatic
active site. These data suggest that NAD+ affects the binding
of 32P-Y4 in a complex way that is neither a straightforward
inhibition nor allosteric facilitation. Further investigation is
needed to understand the role of NAD+ in TGP2 binding
activity.
Dimerization and Supershift of TGP2. Another interesting
characteristic of TGP2 was the apparent dimerization in
SDS-PAGE analysis (Figure 3A) and the supershift that
appeared when TGP2 reached a certain concentration
(Figures 2A and 6A). The crystal structure of lipoamide
dehydrogenase from Azotobacter Vinelandii revealed that
there are hydrogen bond interactions between two subunits/
monomers (25). Moreover, DLDH is inactive as a monomer
because the active site is composed of residues from both
subunits (17). A sufficiently strong native interaction
between the monomers might stabilize DLDH, even in the
presence of SDS at concentrations typically used in SDS-
PAGE. The supershift of TGP2 in mobility shift experiments
can then be explained by a predisposition of the protein to
form dimers and is consistent with the apparent doubling in
size of the observed complex. Thus, at low concentration,
TGP2 might bind to 32P-Y4 as a monomer, but raising the
concentration drives dimer formation, resulting in the
observed supershift. An interesting consequence of this
model is that the dimerization domain is not likely to be
close to the G4-DNA binding domain since this would
disrupt dimerization. Moreover, this positions the G4-DNA
binding domain away from the enzyme active site, which is
at the dimerization interface. This is consistent with our
enzyme activity results indicating that the G4-DNA substrate
did not inhibit DLDH activity (data not shown). Finally,
this model would provide a mechanism for the enzyme to
bind to defined DNA domains and retain enzyme activity to
control the local redox environment as speculated below.
However, an alternative explanation for the supershift is that
a second protein binds to the DNA component of the TGP2-
Y4 complex. This seems less likely since the G4 domain is
quite small and the mechanism for two proteins binding to
this target is not obvious. However, if single-strand binding
proteins are present in low concentration, they could bind
to the single-stranded domains (four per Y4 molecule) and
the result would be a mobility decrease. In this case, we
would expect a variety of lower mobility complexes to result,
but this is not observed.
TGP2 Binding Specificity. Some of the previously re-
ported G4-DNA binding proteins appear to require only the
G4 structure. These include MyoD (a transcription factor
that regulates myogenesis) (9), QUAD (a hepatocyte chro-
matin protein) (30), and the â-subunit of the Oxytricha
telomeric end binding protein (13). Others require a single-
stranded domain along with the G4-structure. These include
topoisomerase II from chicken blood (11), the KEM1 gene
product in yeast (15), and the Tetrahymena G4 DNA binding
protein TGP1 (12). It was reported that topoisomerase II
can only cleave parallel-stranded G4-oligonucleotides whose
sequence corresponds to the human immunoglobulin switch
region, but the KEM1 gene product has no sequence
requirement for its G4-dependent nuclease activity. Though
TGP1 was found to require a single-stranded region in
addition to the G4 structure (12), no other sequence specific-
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ity was apparent for this protein. TGP2 is the first G4-DNA
binding protein reported to require a specific sequence
element at the 5′ end of a single-strand domain. Moreover,
phosphorylation of the 5′ end was also required for optimal
binding. Thus, TGP2 binds to a substrate with the following
characteristics: 5′-PO4-ACTG(X)n-G4-3′ (Figure 5E). The
17 nucleotides forming the 5′ end of Y were originally
randomly selected in the design of oligonucleotides capable
of forming parallel-stranded G4 structures (D. Sen, personal
communication). The reason for the nucleotide sequence
and structural specificity of TGP2 is not clear. A search of
the Genbank database using the program BLASTN revealed
no strong match of Y sequence (31). However, there are
many nucleotide sequences which have the motif 5′-PO4-
ACTG(X)n-G4-3′, and we are currently investigating the
possibility that this sequence motif has functional relevance
with regard to TGP2 binding.
Why Does TGP2/DLDH Bind DNA? Thus far, no DLDH
from any species has been reported to have a direct
interaction with DNA. Interestingly, it has been reported
(32) that the substrate of DLDH, dihydrolipoamide, enhanced
binding of the transcription factor NF-kB to the enhancer
sequence of HIV-1. Moreover, several other thiol reductants
have been found to enhance the binding of NF-kB to the
enhancer element (32), consistent with NF-kB being a
reduction/oxidation-sensitive transcription factor. Several
findings have suggested that binding of transcription factors,
including NF-kB and Sp1, mediates structural changes in
chromatin at the enhancer region bound by the transcription
factors (33, 34). These rearrangements create nuclease
hypersensitive sites, consistent with the idea of alterations
in the DNA structure, which could include formation of G4-
DNA domains. Thus, we suggest the provocative (albeit
speculative) hypothesis that enhancers containing blocks of
guanines, such as the HIV-1 enhancer, might form G4
structures to which TGP2-DLDH could bind and modulate
binding by NF-kB or other redox sensitive transcription
factors (35, 36) by regulating the local redox environment,
or some other mechanisms. We have obtained preliminary
evidence that the HIV-1 enhancer can form G-4 DNA to
which TGP2 binds, and these data will be presented in a
subsequent report.
The formation of single-stranded domains occurs in
genomic DNA during replication, transcription, recombina-
tion, gene rearrangement, and possibly other processes,
including regulation of gene expression. There is substantial
precedent for the existence of single-stranded DNA binding
proteins that bind to transient single-stranded domains formed
during these processes. It is possible that some of these
single-stranded domains may be “protected” by other mech-
anisms, including formation of G4-DNA and binding by G4-
DNA-specific proteins. The scenario of interstrand G4-DNA
formation has been previously proposed (1, 15). In the case
of a transiently denatured single duplex, a G-rich strand could
form an intrastrand G4 domain, while the C-rich comple-
mentary strand would be single stranded (Figure 7). A
protein with the characteristics of TGP2, capable of binding
parallel or antiparallel G-DNA and single-stranded DNA,
could bind to this domain. This process could function as a
molecular switch, as previously proposed by Sen and Gilbert
(1). While these types of models are interesting and provide
the basis for continued experimentation, definitive demon-
stration of the existence and role of G4-DNA in vivo remains
an elusive goal.
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